Although the noxious effects of smoking are well-known and rates of tobacco users are declining, an estimated 38 million American adults still smoke cigarettes. The deleterious consequences of cigarette use are especially evident in the cardiometabolic field, with smokers facing significantly increased risks of cardiovascular disease, hypertension, and diabetes. Not only are smokers 30% to 40% more likely to develop diabetes than nonsmokers, but they also have an increased likelihood of difficulties with insulin dosing and disease management. Despite the critical need for personalized smoking cessation services and their tremendous importance, such programs are lacking within many health systems.
Top 5 Cardiometabolic Health Topics You Can’t Miss at the 14th Annual CMHC
Alarmingly, recent statistics indicate that over one-third of the population has at least one cardiometabolic risk factor, ranging from dyslipidemia and hypertension to diabetes and cardiovascular disease. In the time of a cardiometabolic public health crisis, it is more important than ever for clinicians to equip themselves with the latest therapeutic strategies and protocols in order to prevent, treat, and manage disease. Delivering optimal patient care and enhancing health outcomes requires medical professionals to stay up-to-date on developments and advances in cardiometabolic health through continuing medical education.